Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
this need by designing a multimeric antibody construct able to inhibit neutrophil elastase, the main protease involved in lung damages, to localize specifically to the inflamed lung parenchyma and thereby
-
Biologics Screening Core within the Department of Host Microbe Interactions at St. Jude seeks a skilled and highly motivated candidate with experience in Antibody Discovery . This is a unique opportunity to
-
Scheduled Hours 40 Position Summary Immediate opening for a scientist experienced in antibody development, immunization models and core laboratory operation to join current team. Position will
-
are not curative. To enhance their efficacy, BTK/PI3K inhibitors are commonly combined with anti-CD20 monoclonal antibodies. We suppose that BTK inhibitors (BTKi) disrupt the regulation of CD20
-
: 87384BR This is a training position. The Trainee will be enrolled in a state-approved training program for the Clinical Histocompatibility Scientist (CHS). (https://www.cdph.ca.gov/Programs/OSPHLD/LFS/Pages
-
at matralis-lab , to generate novel compounds (small molecules, proteins, antibody-drug conjugates) that target novel molecular pathways with key roles in cancer progression. (S)he will also work towards
-
offers an exciting opportunity to gain hands-on experience in plant molecular pharming and antibody bioengineering within a translational immunotherapy context. You will receive guidance and development in
-
to work across the two sites. The project, entitled "Developing the next generation of antibody-oligonucleotide conjugates using divinylpyridimidine conjugation" is in the field of Synthetic Organic
-
compared with experiments performed at the IBMM. Main mission) : Our collaborators at the IRMB (UM–CHU Saint-Éloi) have recently discovered that mutations in monoclonal antibodies (mAbs) increase
-
Center for Immunology of Marseille-Luminy (CIML) | Marseille, Provence Alpes Cote d Azur | France | 28 days ago
combining spatial transcriptomics with BCR/TCR repertoire sequencing Producing and screening recombinant monoclonal antibodies (rmAb) from BCR sequences identified in tissues Testing antigen specificity